Covered recipient · General Payments record
STEPHEN GRELECKI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$3,928.09
- Reported across 265 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $509.86 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $317.76 | 21 |
| E.R. Squibb & Sons, L.L.C. | $50.90 | 2 |
| Alkermes, Inc. | $34.47 | 2 |
| ITI, Inc. | $21.75 | 1 |
| Lundbeck LLC | $18.81 | 1 |
| Janssen Pharmaceuticals, Inc | $18.50 | 1 |
| Indivior Inc. | $16.87 | 1 |
| Neurocrine BioSciences, Inc. | $16.80 | 1 |
| Supernus Pharmaceuticals, Inc. | $14.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.55 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837634 | CMS |
| ABBVIE INC. | $18.09 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837636 | CMS |
| ABBVIE INC. | $20.59 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837638 | CMS |
| ABBVIE INC. | $20.30 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837640 | CMS |
| ABBVIE INC. | $6.10 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837642 | CMS |
| ABBVIE INC. | $11.70 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837644 | CMS |
| ABBVIE INC. | $17.99 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837646 | CMS |
| ABBVIE INC. | $14.49 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837648 | CMS |
| ABBVIE INC. | $17.39 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837650 | CMS |
| ABBVIE INC. | $13.58 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837652 | CMS |
| ABBVIE INC. | $15.03 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837654 | CMS |
| ABBVIE INC. | $15.52 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837656 | CMS |
| ABBVIE INC. | $13.86 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837658 | CMS |
| ABBVIE INC. | $11.29 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837660 | CMS |
| ABBVIE INC. | $13.17 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837662 | CMS |
| ABBVIE INC. | $19.06 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837664 | CMS |
| ABBVIE INC. | $11.75 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837666 | CMS |
| ABBVIE INC. | $14.02 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837668 | CMS |
| ABBVIE INC. | $13.58 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837670 | CMS |
| ABBVIE INC. | $16.90 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837672 | CMS |
| ABBVIE INC. | $15.80 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103837674 | CMS |
| Alkermes, Inc. | $15.96 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120508503 | CMS |
| Alkermes, Inc. | $18.51 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120508505 | CMS |
| E.R. Squibb & Sons, L.L.C. | $33.69 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101522208 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.21 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101522180 | CMS |
| Indivior Inc. | $16.87 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144529052 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.75 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143234994 | CMS |
| Janssen Pharmaceuticals, Inc | $18.50 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078090032 | CMS |
| Lundbeck LLC | $18.81 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145920825 | CMS |
| Neurocrine Biosciences, Inc. | $16.80 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150869640 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.00 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147901866 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.